Standards revision will allow for the inclusion of first-ever URAC pharmacy performance measures
WASHINGTON, Feb. 12 /PRNewswire-USNewswire/ -- Today URAC called for public comment on revisions to its Pharmacy Benefit Management (PBM) Version 2.0, Drug Therapy Management (DTM) Version 2.0, and PHARM Core Version 3.0 Standards. These revisions include proposed data collection measures on pharmacy performance, seen as a next critical step in the evolution of pharmacy benefit management.
URAC, one of the nation's leading independent accrediting organizations, is seeking input from any interested parties, including consumers, purchasers, regulators, and industry organizations. Public comments are due no later than March 27, 2009.
PBM and DTM Accreditation Standards, first introduced in July of 2007, were created in an effort to promote industry best practices, encourage quality improvement, and protect and empower consumers. These initial products addressed the need for comprehensive assurance for consumers and purchasers that quality standards are met for consumer protection and empowerment, appropriate access to drugs and pharmacies, patient safety, and disclosure of pricing and contracting terms. PBM and DTM were the first two accreditation products introduced as part of URAC's Pharmacy Quality Management(R) Suite. Since then URAC has added three additional products to its PQM(R) Suite. All accreditation products within the suite were developed by URAC's Pharmacy Accreditation Advisory Group which includes a wide range of stakeholders: employers, consumers, pharmacy consultants, health plans, retail pharmacy, pharmacy benefits management organizations, pharmacy professional organizations, labor, and large public purchasing groups.
Copyright©2009 PR Newswire.
All rights reserved